Details for 2018884002

Up to date per 04.04.2026

Actions

Title / Product Name

THERAPIE FÜR SYSTOLISCHEN BLUTDRUCK MIT SIGMA-1-REZEPTORAGONIST

Status

Granted/Registered

Protection Type

European Patent

(AT-) Application Number

2018884002

EP Publication Number

3716968

E-Number

1872456

Language

PCT Number

US18062853

Publication Date

07.10.2020 A

31.12.2025 B1

Registration Date

31.12.2025

AT Publication Date

15.01.2026

Application Date

28.11.2018

Registration Number

Priorities

28.11.2017

201762591248 P

IPC

A61K 31/341 20060101AFI20210723BHEP

Maximum Duration of Protection

28.11.2038

Owner

Anavex Life Sciences Corp.51 West 52nd Street 7th Floor New York, NY 10019US

Representative

No representatives present

Inventor

MISSLING, Christopher, U.c/o Anavex Life Sciences Corp. 51 West 52nd Street 7th Floor New York NY 10019US

Information about Fees